The outcome of the world’s response to COVID-19 depends largely on the success of longstanding research and development (R&D) partnerships between public and private sector institutions, including national governments, universities, and pharmaceutical companies. So it’s crucial that governments resist the impulse to undermine these relationships by adopting policies inimical to private sector research […]
Tag: research
Trade Barriers Kill Innovation
Creating medicine is a complex and expensive business. While U.S. biopharmaceutical companies lead the world in drug development, international trade practices can stem the flow of innovation to new markets, depriving patients in need. Limited market penetration also means fewer resources to re-invest in the most successful engine for life-saving advancements on […]
Analyzing health records, insurance claims speeds new treatments
Historically the trove of medical and para-medical information known as “real-world evidence,” including health records but also insurance claims and patient registries, has mostly been used as a source for additional evaluation of the efficacy of existing drugs after they have already been approved. But […]
Combo Therapy Offers Better Control of Diabetes, Study Suggests
This week brought exciting news for type 2 diabetes patients as well as the medical and public health professionals who are working to control this potentially deadly disease: a new study published in The Lancet suggests that using two common drugs for controlling diabetes […]
How to improve access to medicines — and how NOT to
With the UN General Assembly convening in New York to discuss all manner of policy issues, one high-profile area of debate is the appropriate role of governments and regulators in ensuring that as many people as possible have access to the medicines they need. […]